510(k) K193649
K193649 is an FDA 510(k) premarket notification submitted by HORIBA ABX SAS for the device "Yumizen C1200 Creatinine PAP". The FDA issued a decision of Substantially Equivalent on May 10, 2021. The device falls under product code JFY (Enzymatic Method, Creatinine), a Class II device regulated under 21 CFR 862.1225. HORIBA ABX SAS has 36 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 10, 2021
- Date Received
- Dec 30, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzymatic Method, Creatinine
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for HORIBA ABX SAS? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.